Li 2005.

Methods	Parallel design Improvement of post‐stroke depression and augmentation of rehabilitation
Participants	Country: China Setting: inpatient Stroke criteria: all stroke, clinical diagnosis plus confirmation on imaging (though not clear whether a relevant lesion had to be present) Depression according to CCMD‐II‐R Treatment: 74 participants Control: 74 participants Participaients in the treatment and control groups were selected from a group of 368 stroke patients with an average age of 57 ± 11.8 years, age range 33 to 84 years, 240 men Excluded: previous psychiatric disorders, severe dementia, aphasia, consciousness disturbance
Interventions	Treatment: paroxetine 20 mg daily plus routine stroke treatment Control: routine stroke treatment Duration of treatment: 4 weeks Duration of follow‐up (end of treatment to study end): 0
Outcomes	HAMD SSS Deaths Side effects not recorded
Funding source	Source of funding not stated
Notes	−
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Unclear risk	Randomisation method not described
Allocation concealment (selection bias)	Unclear risk	No description
Blinding of participants and personnel (performance bias) All outcomes	High risk	No placebo
Blinding of outcome assessment (detection bias) All outcomes	Unclear risk	Not stated whether blinded
Incomplete outcome data (attrition bias) All outcomes	Low risk	Analysed according to allocated treatment group, no participant dropped out
Selective reporting (reporting bias)	Unclear risk	No protocol
Other bias	Unclear risk	No description of differences between treatment and control group